Table 2 Survival analysis of 86 patients depending on intravenous administration of zoledronic acid
| Â | ZOL group n (%) | Control group n (%) |
|---|---|---|
Total | 40 (100%) | 46 (100%) |
Deaths | 1 (2%) | 5 (11%) |
Relapses 1 | 3 (8%) | 7 (15%) |
Distant metastasis | 3 (8%) | 5 (11%) |
Local recurrence | 1 (2%) | 4 (9%) |